⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for recurrent fallopian tube undifferentiated carcinoma

Every month we try and update this database with for recurrent fallopian tube undifferentiated carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerNCT02839707
Fallopian Tube ...
Ovarian High Gr...
Ovarian Seromuc...
Primary Periton...
Recurrent Fallo...
Recurrent Fallo...
Recurrent Fallo...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Plati...
Recurrent Plati...
Recurrent Plati...
Recurrent Prima...
Recurrent Prima...
Recurrent Prima...
Recurrent Prima...
Atezolizumab
Bevacizumab
Computed Tomogr...
Pegylated Lipos...
Quality-of-Life...
18 Years - National Cancer Institute (NCI)
Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian CancerNCT06393751
Platinum-Refrac...
Platinum-Refrac...
Platinum-Refrac...
Recurrent Fallo...
Recurrent Fallo...
Recurrent Fallo...
Recurrent Fallo...
Recurrent Fallo...
Recurrent High ...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Plati...
Recurrent Plati...
Recurrent Plati...
Recurrent Prima...
Recurrent Prima...
Recurrent Prima...
Recurrent Prima...
Recurrent Prima...
Bevacizumab
Biospecimen Col...
Computed Tomogr...
Magnetic Resona...
Paclitaxel
Tolinapant
18 Years - National Cancer Institute (NCI)
Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic AgentsNCT04739800
Fallopian Tube ...
Ovarian Seromuc...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Refrac...
Recurrent Fallo...
Recurrent Fallo...
Recurrent Fallo...
Recurrent Fallo...
Recurrent Fallo...
Recurrent Fallo...
Recurrent Low G...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Plati...
Recurrent Plati...
Recurrent Plati...
Recurrent Prima...
Recurrent Prima...
Recurrent Prima...
Recurrent Prima...
Recurrent Prima...
Recurrent Prima...
Refractory Fall...
Refractory Fall...
Refractory Fall...
Refractory Fall...
Refractory Fall...
Refractory Fall...
Refractory Low ...
Refractory Ovar...
Refractory Ovar...
Refractory Ovar...
Refractory Ovar...
Refractory Ovar...
Refractory Ovar...
Refractory Ovar...
Refractory Ovar...
Refractory Prim...
Refractory Prim...
Refractory Prim...
Refractory Prim...
Refractory Prim...
Refractory Prim...
Biospecimen Col...
Cediranib Malea...
Computed Tomogr...
Computed Tomogr...
Durvalumab
Echocardiograph...
Magnetic Resona...
Multigated Acqu...
Olaparib
Paclitaxel
Pegylated Lipos...
Topotecan Hydro...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: